Cargando…
老年多发性骨髓瘤患者接受自体造血干细胞移植的疗效和安全性:单中心回顾性研究
OBJECTIVE: To evaluate the efficacy and safety of autologous hematopoietic stem cell transplantation (auto-HSCT) in elderly patients (≥65 years old) with multiple myeloma (MM). METHODS: From June 1, 2006 to July 31, 2020, 22 MM patients (≥65 years old) who were diagnosed in the First Affiliated Hosp...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980643/ https://www.ncbi.nlm.nih.gov/pubmed/35381675 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.02.009 |
Ejemplares similares
-
自体造血干细胞移植治疗老年淋巴瘤19例的疗效及安全性
Publicado: (2018) -
多发性骨髓瘤患者自体造血干细胞移植后长期随访的单中心结果
Publicado: (2017) -
含新药诱导化疗序贯自体造血干细胞移植、维持治疗策略治疗多发性骨髓瘤300例——单中心回顾性研究
Publicado: (2022) -
149例多发性骨髓瘤患者自体外周血造血干细胞动员采集的回顾性分析
Publicado: (2015) -
单中心BCL-2抑制剂治疗伴t(11;14)的复发/难治性多发性骨髓瘤患者疗效及安全性分析
Publicado: (2022)